GENB Earnings Date: Nov 5, 2026 (Estimated) — Generate Biomedicines, Inc.

NASDAQ

Updated Oct 30, 2026

Price $14.90

Market Cap $2.0B

P/E -7.3

52W Range $11.00 – $22.67

Next Earnings Nov 5, 2026 (est.)

When is GENB's next earnings date?

Generate Biomedicines, Inc. (GENB) is expected to report earnings on Thursday, November 5, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.51 on revenue of $7.8M.

How did GENB do in its last earnings report?

In its most recent report on Aug 6, 2026 (Q2 2026), Generate Biomedicines, Inc. posted EPS of -$0.52 versus the -$0.51 estimate, a miss of 6.1%. Revenue was $6.3M against a $5.3M estimate. The stock's 1-day post-earnings move was -4.1%.

How much does GENB stock move after earnings?

GENB beat EPS estimates in 0 of its last 2 reported quarters. Over the last 2 reports the stock moved an average of 7.7% (up or down) in the day after earnings.

About Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.